Phialogics is developing a pipeline of bi-functional, bi-specific and multi-specific molecules to treat autoimmune diseases. Our unique First-in-Class immunomodulatory approach has a proof of concept in several translational in vivo models as well as in patient-derived materials ex vivo.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Swiss Innovation Park Basel Area, Hegenheimermattweg 167a, Allschwil,basel 4123,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.phialogics.com
- Keywords
- spans Immunology.
- HQ
- Allschwil, Basel
Phialogics - The Native Biologics Platform Company Questions
Phialogics - The Native Biologics Platform Company's website is http://www.phialogics.com
Phialogics - The Native Biologics Platform Company's LinkedIn profile is https://ch.linkedin.com/company/phialogics
Phialogics - The Native Biologics Platform Company has
5 employees.
View email and phone details for 5
employees at Phialogics - The Native Biologics Platform Company.
Phialogics - The Native Biologics Platform Company's industry is
Biotechnology Research
Phialogics - The Native Biologics Platform Company's top competitors are
Alentis Therapeutics,
Endolease-Systems,
Salvina Therapeutics,
Anavo Therapeutics Bv,
Engimmune Therapeutics,
Panosome Gmbh,
Immuneadvice Gmbh,
Tcelltech Gmbh,
Incephalo,
Baselaunch.
Phialogics - The Native Biologics Platform Company's categories are Biotechnology Research
Phialogics - The Native Biologics Platform Company's founding year is 2022
